Shanghai Nianxing Industrial Co., Ltd
China
Product Name: Myristoyl-L-carnitine Hydrochloride
Price:
Purity: 98.0%
Stocking Period: 10 Day
Contact: Yang

1259519-18-0

1259519-18-0 structure

1259519-18-0 structure

Name: Neratinib-d6
Chemical Name: Neratinib-d6
CAS Number: 1259519-18-0
Molecular Formula: C₃₀H₂₃D₆ClN₆O₃
Molecular Weight: 563.08
Catalog: Signaling Pathways JAK/STAT Signaling EGFR
Create Date: 2021-10-07 15:47:33
Modify Date: 2024-01-12 10:54:02
Neratinib-d6 (HKI-272-d6) is the deuterium labeled Neratinib. Neratinib (HKI-272) is an orally available, irreversible tyrosine kinase inhibitor with IC50s of 59 nM and 92 nM for HER2 and EGFR, respectively.

Name	Neratinib-d6

Description	Neratinib-d6 (HKI-272-d6) is the deuterium labeled Neratinib. Neratinib (HKI-272) is an orally available, irreversible tyrosine kinase inhibitor with IC50s of 59 nM and 92 nM for HER2 and EGFR, respectively.
Related Catalog	Research Areas >> Cancer Signaling Pathways >> JAK/STAT Signaling >> EGFR Signaling Pathways >> Protein Tyrosine Kinase/RTK >> EGFR
In Vitro	Stable heavy isotopes of hydrogen, carbon, and other elements have been incorporated into drug molecules, largely as tracers for quantitation during the drug development process. Deuteration has gained attention because of its potential to affect the pharmacokinetic and metabolic profiles of drugs[1].
References	[1]. Russak EM, et al. Impact of Deuterium Substitution on the Pharmacokinetics of Pharmaceuticals. Ann Pharmacother. 2019;53(2):211-216. [2]. Rabindran SK, et al. Antitumor activity of HKI-272, an orally active, irreversible inhibitor of the HER-2 tyrosine kinase. Cancer Res, 2004, 64(11), 3958-3965. [3]. Yoshioka T, et al. Antitumor activity of pan-HER inhibitors in HER2-positive gastric cancer. Cancer Sci. 2018 Apr;109(4):1166-1176.

Molecular Formula	C₃₀H₂₃D₆ClN₆O₃
Molecular Weight	563.08